First ALS Drug Approved in Over 2 Decades

A social media sensation has finally paid off. The U.S. Food and Drug Administration (FDA) has recently approved the first drug to combat amyotrophic lateral sclerosis, or ALS, in 22 years. The new drug, Radicava, has shown that it can slow progress of the physical conditions related to the disease by Continue Reading

The Phenomenex Story: Part I

One might expect the CEO of a global separation sciences company to be a chemistry graduate, with in-depth training in analytical chemistry. In fact, Persian-born Fasha Mahjoor, the charismatic CEO of Phenomenex, failed all of the chemistry exams at his English boarding school before going on to acquire a Masters in architecture.

Presenting the 2016 Humanity in Science Award Winner…

The Humanity in Science Award was created in 2015 to recognize outstanding developments in science that could change human lives for the better.

Humanity in Science: Optimizing Diagnostics of Rare Diseases in Newborns

The Humanity in Science Award was created in 2015 to recognize outstanding developments in science that could change human lives for the better. There were many runners-up who did (and do!) amazing things for humanity. Recently, The Analytical Scientist sat down with each of them to catch up, and find out how their ventures have progressed in the last 12 months.

Humanity in Science: Combating Counterfeit with Capillary Electrophoresis

The Humanity in Science Award was created in 2015 to recognize outstanding developments in science that could change human lives for the better. There were many runners-up who did (and do!) amazing things for humanity. Recently, The Analytical Scientist sat down with each of them to catch up, and find out how their ventures have progressed in the last 12 months.

CEO Jumps Off Buildings (Again!)

On September 7, Phenomenex and Neoteryx CEO Fasha Mahjoor joined a group of fellow humanitarians through The City Three Peaks Challenge to support educational charity The Outward Bound Trust by abseiling a trio of London’s most iconic skyscrapers.

The London to Paris Bike Ride: Meet the Cyclists

Phenomenex is proud to introduce a group of courageous riders as they approach The London to Paris Bike Ride: three days, two countries, and nearly 500 kilometers—all for a charity of their choice.

Terrell Mathews Bikes for Outward Bound California (Phenomenex US)

Earlier this year, a friend from my company’s office in the Netherlands attained corporate sponsorship to sanction employee participation in a charity fundraising bicycle ride from London to Paris. I put my name in the hat for the hell of it.

Helen Whitby Cycles for Kids (Phenomenex UK)

When I came back to work briefly in June to begin a few catch-up days, I was asked if I’d like to step in for an injured colleague participating in the London to Paris Cycling Challenge. I suspect they knew I wouldn’t be able to say no! There was just one problem: my eldest daughter’s 5th birthday is the day the ride begins.